As I understand blind trials, I believe the clinicians probably recommended the expansion of the trial, and I wouldn't be surprised if they were enthusiastic about what they're seeing, but they won't give detailed data.

As I remember the trial, I believe that some receive a placebo cream, and unblinding really shows who received which. Remember, the company hasn't ever officially told us they're enrolling patients with psoriasis and other skin diseases. We believe this is the case from what some were privately told, but I don't believe they've ever put out anything official stating that's what they're doing. I'm frankly uncertain if this is the same trial that Mediq referred to, or if they too have something else going on.

I believe that confidentiality agreements may be the company's excuse for not giving us more information, but frankly, I believe that during things like quarterlies, an update of all that happens can be done in general terms that give some guidance as to when trials should be concluded, and also confirm that confidentiality agreements prevent more detailed discussion. The company is being exceptionally conservative with what they're willing to say.

Gary